 antiinflammatory-antioxid treatment methan sulfonanilid allergen-induc asthma group asthmat patient biphas bronchospast respons dermatophagoid allergen extract double-blind fashion earli late asthmat reaction inhal challeng end treatment period nimesulid sulfonanilid antioxid properti placebo bronchial respons hour allergen inhal challeng dose allergen ear decreas sever lar maximum fall similar end treatment period group patient nimesulid bronchial respons allergen inhal end treatment period result hypothesi product oxygen-fre radic signific role develop bronchial hyperrespons late phase reaction asthma